Microdosing Cannabis: A New Hope in Alzheimer's Treatment

A Brazilian study has shown that microdoses of cannabis extract can positively impact patients with mild Alzheimer’s disease without causing the 'high' typically associated with cannabis. This research opens up new possibilities for using cannabis in dementia treatment, emphasizing non-psychoactive doses.

A recent Brazilian study has revealed promising results for the use of cannabis microdosing in the treatment of mild Alzheimer's disease. Conducted by Professor Francisney Nascimento and his team at UNILA, the research highlights the potential cognitive benefits of cannabis without the psychoactive effects.

The controlled trial involved 24 elderly volunteers, who received daily doses of cannabis oil with minimal THC and CBD concentrations. The study observed stabilization in cognitive test scores compared to a placebo group, suggesting potential therapeutic benefits.

Despite requiring further research due to its small sample size, the study marks a pioneering step in Alzheimer's treatment, proposing a cultural shift towards using cannabis-derived substances without the associated stigma of recreational use.

(With inputs from agencies.)